SOX9 and lung carcinoma: When SNAI2 and SOX9 are co-expressed in human lung carcinoma, SNAI2 can protect SOX9 avoid from ubiquitin-mediated proteasomal degradation, which is necessary for SOX9 to promote cancer stem cells and maintain its stem-like phenotype [4].